Human Recombinant PCSK9 protein, His Tag (V2LY-0526-LY5996)

Go to compare Compare Online Inquiry
Request for COA
Datasheet Target Q & As Review & reward Protocols Associated Products

Basic Information

Expressed Host
HEK293 Cells
Protein Species
Human
Tag
His Tag
Protein Construction
This product is Human Recombinant PCSK9 protein, His Tag consist of Amino Acid: 31-692 and predicts a molecular mass of 73.03 kDa.
Molecule Mass
73.03 kDa
Verified
HPLC
Sequence
Amino Acid: 31-692
Species
Human

Formulations & Storage [For reference only, actual COA shall prevail!]

Purity
≥95% as determined by SDS-PAGE. ≥90% as determined by SEC-HPLC. ≥90% as determined by SEC-MALS(Routinely tested).
Endotoxin
Please contact us for more information.
Format
Lyophilized
Reconstitution
Allow the vial and reconstitution buffer to equilibrate to room temperature. Briefly centrifuge or tap down the vial to ensure that all lyophilized powder is collected at the bottom of the vial. For the reconstitution of this product, we recommend adding PBS or sterile water to achieve a final antibody concentration of 1 mg/mL. Allow the vial to reconstitute for 10-15 minutes at room temperature with gentle agitation. Avoid vigorous shaking that can cause foaming and antibody denaturation. Aliquot into volumes based on your experiment and store liquid protein at -20°C or -80°C for long time.
Buffer
Lyophilized from sterile PBS
Preservative
None
Storage
Samples are stable for up to twelve months from date of receipt at -20°C to -80°C. Store it under sterile conditions at -20°C to -80°C. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
More Infomation

Target

Full Name
Proprotein Convertase Subtilisin/Kexin Type 9
Function
Crucial player in the regulation of plasma cholesterol homeostasis. Binds to low-density lipid receptor family members: low density lipoprotein receptor (LDLR), very low density lipoprotein receptor (VLDLR), apolipoprotein E receptor (LRP1/APOER) and apolipoprotein receptor 2 (LRP8/APOER2), and promotes their degradation in intracellular acidic compartments (PubMed:18039658).
Acts via a non-proteolytic mechanism to enhance the degradation of the hepatic LDLR through a clathrin LDLRAP1/ARH-mediated pathway. May prevent the recycling of LDLR from endosomes to the cell surface or direct it to lysosomes for degradation. Can induce ubiquitination of LDLR leading to its subsequent degradation (PubMed:18799458, PubMed:17461796, PubMed:18197702, PubMed:22074827).
Inhibits intracellular degradation of APOB via the autophagosome/lysosome pathway in a LDLR-independent manner. Involved in the disposal of non-acetylated intermediates of BACE1 in the early secretory pathway (PubMed:18660751).
Inhibits epithelial Na+ channel (ENaC)-mediated Na+ absorption by reducing ENaC surface expression primarily by increasing its proteasomal degradation. Regulates neuronal apoptosis via modulation of LRP8/APOER2 levels and related anti-apoptotic signaling pathways.
Biological Process
Apoptotic processIEA:UniProtKB-KW
Cellular response to insulin stimulusBy SimilarityISS:HGNC-UCL
Cellular response to starvationBy SimilarityISS:HGNC-UCL
Cholesterol homeostasisManual Assertion Based On ExperimentIMP:HGNC-UCL
Cholesterol metabolic processIEA:UniProtKB-KW
Kidney developmentBy SimilarityISS:HGNC-UCL
Lipoprotein metabolic processIEA:Ensembl
Liver developmentBy SimilarityISS:HGNC-UCL
Low-density lipoprotein particle receptor catabolic processManual Assertion Based On ExperimentIDA:UniProtKB
Lysosomal transportManual Assertion Based On ExperimentIDA:BHF-UCL
Negative regulation of low-density lipoprotein particle clearanceManual Assertion Based On ExperimentIDA:BHF-UCL
Negative regulation of low-density lipoprotein particle receptor bindingManual Assertion Based On ExperimentIDA:BHF-UCL
Negative regulation of low-density lipoprotein receptor activityManual Assertion Based On ExperimentIDA:BHF-UCL
Negative regulation of receptor internalizationManual Assertion Based On ExperimentIDA:ComplexPortal
Negative regulation of receptor recyclingManual Assertion Based On ExperimentIDA:BHF-UCL
Negative regulation of receptor-mediated endocytosis involved in cholesterol transportManual Assertion Based On ExperimentIDA:BHF-UCL
Negative regulation of sodium ion transmembrane transporter activityManual Assertion Based On ExperimentIDA:BHF-UCL
NeurogenesisBy SimilarityISS:HGNC-UCL
Neuron differentiationBy SimilarityISS:HGNC-UCL
Phospholipid metabolic processIEA:Ensembl
Positive regulation of low-density lipoprotein particle receptor catabolic processManual Assertion Based On ExperimentIDA:BHF-UCL
Positive regulation of neuron apoptotic processManual Assertion Based On ExperimentIMP:HGNC-UCL
Positive regulation of receptor internalizationManual Assertion Based On ExperimentIDA:BHF-UCL
Protein autoprocessingManual Assertion Based On ExperimentIDA:HGNC-UCL
Regulation of neuron apoptotic processISS:UniProtKB
Regulation of signaling receptor activityManual Assertion Based On ExperimentIDA:BHF-UCL
Triglyceride metabolic processIEA:Ensembl
Cellular Location
Cytoplasm
Secreted
Endosome
Lysosome
Cell surface
Endoplasmic reticulum
Golgi apparatus
Autocatalytic cleavage is required to transport it from the endoplasmic reticulum to the Golgi apparatus and for the secretion of the mature protein. Localizes to the endoplasmic reticulum in the absence of LDLR and colocalizes to the cell surface and to the endosomes/lysosomes in the presence of LDLR. The sorting to the cell surface and endosomes is required in order to fully promote LDLR degradation.
Involvement in disease
Hypercholesterolemia, familial, 3 (FHCL3):
A form of hypercholesterolemia, a disorder of lipoprotein metabolism characterized by elevated serum low-density lipoprotein (LDL) cholesterol levels, which result in excess deposition of cholesterol in tissues and leads to xanthelasma, xanthomas, accelerated atherosclerosis and increased risk of premature coronary heart disease. FHCL3 inheritance is autosomal dominant.
PTM
Cleavage by furin and PCSK5 generates a truncated inactive protein that is unable to induce LDLR degradation.
Undergoes autocatalytic cleavage in the endoplasmic reticulum to release the propeptide from the N-terminus and the cleavage of the propeptide is strictly required for its maturation and activation. The cleaved propeptide however remains associated with the catalytic domain through non-covalent interactions, preventing potential substrates from accessing its active site. As a result, it is secreted from cells as a propeptide-containing, enzymatically inactive protein.
Phosphorylation protects the propeptide against proteolysis.
Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Human Recombinant PCSK9 protein, His Tag?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...

Alternative Versions

Human Recombinant PCSK9 (D374Y) protein, His Tag (CAT#: V2LY-0526-LY5992)

Human Recombinant PCSK9 (D374Y) protein, Fc Tag (CAT#: V2LY-0526-LY5993)

Human Recombinant PCSK9 (D374Y) protein, Biotin Conjugated, Fc Tag (CAT#: V2LY-0526-LY5994)

Human Recombinant PCSK9 protein, Biotin Conjugated, His & AVI Tag (CAT#: V2LY-0526-LY5995)

Human Recombinant PCSK9 protein, His Tag-1 (CAT#: V2LY-0526-LY5997)

Human Recombinant PCSK9 protein, His Tag-2 (CAT#: V2LY-0526-LY5998)

Human Recombinant PCSK9 protein, Fc Tag (CAT#: V2LY-0526-LY5999)

Mouse Recombinant PCSK9 protein, His Tag (CAT#: V2LY-0526-LY8740)

Mouse Recombinant PCSK9 protein, Fc Tag (CAT#: V2LY-0526-LY8741)

Rat Recombinant PCSK9 protein, His Tag (CAT#: V2LY-0526-LY9540)

Related Products

Rat Anti-PCSK9 Recombinant Antibody (15H129) (CAT#: CBMAB-P1104-YC)

Human Recombinant PCSK9RC1 (D374Y, V474I, G670E) protein, Biotin Conjugated, His Tag (CAT#: V2LY-0526-LY240)

Rabbit Anti-PCSK9 Recombinant Antibody (
7F2) (CAT#: V2LY-0725-LY1128)

Human Recombinant PCSK9 (D374Y) protein, His Tag (CAT#: V2LY-0526-LY5992)

Mouse Recombinant PCSK9 protein, His Tag (CAT#: V2LY-0526-LY8740)

Mouse Anti-PCSK9 Recombinant Antibody (CBXF-0041) (CAT#: CBMAB-F1310-CQ)

Rhesus Recombinant PCSK9 protein, His Tag (CAT#: V2LY-0526-LY9777)

Rat Anti-PCSK9 Recombinant Antibody (CBYC-P228) (CAT#: CBMAB-P1106-YC)

Human Recombinant PCSK9 protein, His Tag-1 (CAT#: V2LY-0526-LY5997)

Human Recombinant PCSK9 protein, Biotin Conjugated, His & AVI Tag (CAT#: V2LY-0526-LY5995)

Isotype control

For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

online inquiry
Online Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.